TY  - GEN
AU  - McBride,Jacqueline M
AU  - Jiang,Jenny
AU  - Abbas,Alexander R
AU  - Morimoto,Alyssa
AU  - Li,Jing
AU  - Maciuca,Romeo
AU  - Townsend,Michael
AU  - Wallace,Daniel J
AU  - Kennedy,William P
AU  - Drappa,Jorn
TI  - Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study
SN  - 1529-0131
PY  - 2013///0110
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Antinuclear
KW  - blood
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Neutralizing
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Genome-Wide Association Study
KW  - Humans
KW  - Immunoglobulin G
KW  - Injections, Intravenous
KW  - Interferons
KW  - genetics
KW  - Lupus Erythematosus, Systemic
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Placebos
KW  - Severity of Illness Index
KW  - Transcriptome
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/art.34632
ER  -